288 related articles for article (PubMed ID: 25200076)
21. Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor.
Song D; He H; Sinha I; Hases L; Yan F; Archer A; Haldosen LA; Zhao C; Williams C
Cancer Lett; 2021 May; 506():23-34. PubMed ID: 33652085
[TBL] [Abstract][Full Text] [Related]
22. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.
Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K
Cancer Res; 2014 Jul; 74(14):3983-94. PubMed ID: 24830720
[TBL] [Abstract][Full Text] [Related]
24. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor.
Watabe T; Yoshida K; Shindoh M; Kaya M; Fujikawa K; Sato H; Seiki M; Ishii S; Fujinaga K
Int J Cancer; 1998 Jul; 77(1):128-37. PubMed ID: 9639404
[TBL] [Abstract][Full Text] [Related]
25. Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells.
Dahlman-Wright K; Qiao Y; Jonsson P; Gustafsson JÅ; Williams C; Zhao C
Carcinogenesis; 2012 Sep; 33(9):1684-91. PubMed ID: 22791811
[TBL] [Abstract][Full Text] [Related]
26. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
[TBL] [Abstract][Full Text] [Related]
27. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
Detry C; Lamour V; Castronovo V; Bellahcène A
Bone; 2008 Feb; 42(2):422-31. PubMed ID: 18088579
[TBL] [Abstract][Full Text] [Related]
28. The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes.
Hayward CP; Liang M; Tasneem S; Soomro A; Waye JS; Paterson AD; Rivard GE; Wilson MD
PLoS One; 2017; 12(3):e0173991. PubMed ID: 28301587
[TBL] [Abstract][Full Text] [Related]
29. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
[TBL] [Abstract][Full Text] [Related]
32. PKCθ-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration.
Belguise K; Cherradi S; Sarr A; Boissière F; Boulle N; Simony-Lafontaine J; Choesmel-Cadamuro V; Wang X; Chalbos D
Cancer Lett; 2017 Jan; 385():97-107. PubMed ID: 27816489
[TBL] [Abstract][Full Text] [Related]
33. The urokinase plasminogen activator system in breast cancer invasion and metastasis.
Tang L; Han X
Biomed Pharmacother; 2013 Mar; 67(2):179-82. PubMed ID: 23201006
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the uPA gene in various grades of human glioma cells.
Lakka SS; Bhattacharya A; Mohanam S; Boyd D; Rao JS
Int J Oncol; 2001 Jan; 18(1):71-9. PubMed ID: 11115541
[TBL] [Abstract][Full Text] [Related]
35. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene.
Lengyel E; Wang H; Stepp E; Juarez J; Wang Y; Doe W; Pfarr CM; Boyd D
J Biol Chem; 1996 Sep; 271(38):23176-84. PubMed ID: 8798512
[TBL] [Abstract][Full Text] [Related]
36. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.
Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF
Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085
[TBL] [Abstract][Full Text] [Related]
37. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
[TBL] [Abstract][Full Text] [Related]
38. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
39. PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer.
Gao Y; Ma X; Lu H; Xu P; Xu C
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36524374
[TBL] [Abstract][Full Text] [Related]
40. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
Mahanivong C; Yu J; Huang S
Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
